BDNF and neoplasm: We chose BDNF and cAMP as candidate treatments because previous studies have shown that neurotrophic factors are neuroprotective in RGCs across various models (5, 22, 36), and we sought to avoid treatments that directly interact with tumor suppressors or oncogenes (36).